Background-The accepted management of Mirizzi's syndrome is surgical, but endoscopic and percutaneous management have been described. Aim-To review our experience of endos-
tectomy. ' 2The established treautent is surgical but with the development of endoscopic and percutaneous biliary techniques non-surgical therapy has been described. We describe our experience of Mirizzi's syndrome, emphasising the role of ERCP in diagnosis and treatment.
Methods
We searched our database for all patients with a cholangiographic diagnosis of Mirizzi's syndrome between March 1989 and June 1995 and reviewed their notes, and retrograde cholangiograms. Demographic details, presentation, clinical and cholangiographic findings, endoscopic and surgical treatment, and complications of treatment were recorded. Patients were followed up by contacting their primary physician or referring doctor. Follow up was judged complete if the patient had cholecystectomy, cholangiography showed clear ducts, and they were discharged from review, or if the patient died.
Mirizzi's syndrome was described in 1948 and consists of a stone impacted in the neck of the gall bladder or in the cystic duct, causing inflammation and extrinsic compression of the common duct, leading to obstructive jaundice. Mirizzi's syndrome may be subdivided into types I and II: in the first there is extrinsic compression of the common duct by an inflamed or enlarged gall bladder (Fig 1) while in type II the stone erodes from the gall bladder or the cystic duct into the common duct resulting in a cholecystcholedochal fistula (Fig 2) . The syndrome is rare occurring in only 0-7-110% of patients undergoing cholecys- corporeal shockwave lithotripsy, and common duct bile stents. Nine patients were treated with long term stenting and of these five are alive and well at follow up ranging from four months to five years and two months. Four patients in this group died, two of non-biliary causes, another from bronchopneumonia 10 days after ERCP, and one of secondary biliary cirrhosis at two years and seven months. The remaining patient in this group is awaiting extracorporeal shockwave lithotripsy of the gall bladder.
Complications of endoscopic treatment occurred in four of 25 patients: (case 7) bronchopneumonia after ERCP, (case 23) acute cholecystitis after stenting, (case 1 1) liver abscess treated conservatively with antibiotics, and (case 5) secondary biliary cirrhosis.
The overall mortality of the group was seven of 25, with a 30 day mortality of two of 25. Four of seven deaths were biliary related: (case 5) secondary biliary cirrhosis; (case 7) bronchopneumonia after ERCP; (case 1 1) carcinoma of gall bladder; (case 22) multiorgan failure secondary to prolonged haemobilia from a pseudoaneurysm of the cystic artery.
Discussion
Mirizzi syndrome, a rare complication of gallstone disease, is increasingly recognised with the widespread availability of cholangiography. In the past the diagnosis was often first made at laparotomy, and because of the severe inflammation in Calot's triangle associated with a shrunken gall bladder, the risk of bile duct injury was high. The syndrome, as originally described, comprised a stone impacted in the cystic duct or neck of the gall bladder and a functional disorder of a putative sphincter within the common hepatic duct, without any lesion of the common bile duct.3 Inflammation, aberrant vessels or an impacted cystic duct stone were thought to stimulate contraction of this 'sphincter' resulting in obstructive jaundice. It is now known that no such 'sphincter' exists and that biliary obstruction results from extrinsic compression of the common duct by the inflamed gall bladder and that the inflammatory process may result in common duct disruption.
In 1982 McSherry4 classified Mirizzi's syndrome into type I and type II based on cholangiographic findings at ERCP. Type I is present when there is extrinsic compression of the common duct by a stone in the gall bladder or in the cystic duct (Fig 1) . Type II is present when a cholecystcholedochal fistula exists (Fig 2) . Type II has been further subclassified by Csendes et al5 into three types depending on the size of the defect in the common ducttype II: erosion of less than one third the circumference of the bile duct; type III: erosion of up to two thirds of the common duct; type IV: complete destruction of the entire wall of the common duct. Endoscopic management of Mirizzi syndrome comprises biliary drainage of the common duct with or without gall bladder drainage, and attempted gall stone removal with either basket or balloon, mechanical, electrohydraulic or extracorporeal lithotripsy or dissolution therapy. Endoscopic sphincterotomy is followed by either placement of a nasobiliary catheter or more commonly insertion of an indwelling prosthesis into the common bile duct, cystic duct or both.' '2 After resolution of jaundice or cholangitis attempts are made to clear the stones when surgery is not deemed appropriate. The largest published series of solely endoscopic management of Mirizzi syndrome is by Binmoeller et al. 3 In this series electrohydraulic lithotripsy was administered at ERCP under cholangioscopic guidance to 14 patients with Mirizzi's syndrome. In all patients the stone was impacted distally in the cystic duct and stone size ranged from 1-5 cm to greater than 3 cm. Stones were cleared in all 14 patients with only one complication: there was leakage of contrast from the duct system into the peritoneal cavity after removal of a large 3 5 cm stone. This leak was caused by pressure necrosis from the large stone rather than injury to the duct by the electrohydraulic lithotripsy probe and resolved spontaneously with conservative management. The authors conclude that this is a safe and effective alternative to surgery. Limitations of this technique include the need for considerable expertise at ERCP, cost of equipment including mother and baby scope system, and electrohydraulic lithoprobe per patient treatment session and the procedure is time consuming. In addition stones must be accessible to the electrohydraulic lithoprobe and hence Mirizzi's syndrome patients with a stone impacted in Hartmann's pouch are not suitable for this treatment (12 of 25 of our patients).
In our series almost half had definitive surgery after endoscopic therapy. As can be seen from Table I In conclusion ERCP plays an important part in diagnosis and provides not only a roadmap for surgery but permits therapeutic decompression of the biliary tree as a temporising measure before surgery. In some patients endoscopic clearance of stones is possible, and long term stenting for those in whom clearance is not achieved is an alternative, effective option to surgery -with the caveat that these patients should be followed up at regular intervals to prevent complications. 
